Therapeutic Considerations When Treating HER2-positive Metastatic Breast Cancer
Crossref DOI link: https://doi.org/10.1007/s12609-014-0155-y
Published Online: 2014-07-12
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
O’Sullivan, Ciara C.
Smith, Karen L.
Text and Data Mining valid from 2014-07-12